Marine biotechnology company harnessing marine micro-organisms to develop high value products for application across the pharmaceutical, personal care and nutrition sectors.

The company is based at the European Centre for Marine Biotechnology in Oban, Scotland with a corporate office and labs in Edinburgh.

Central to the company is its development of new pharmaceuticals from its marine microbial collection to address areas of high unmet medical need including auto-immune diseases; tissue-damage caused by chronic and degenerative diseases and; antibiotics to treat drug-resistant infections.

Through a unified approach to the discovery of new functional actives, Aquapharm recognises that its collection of marine microbes also holds great potential for the food, beverage and personal care sectors and its Oceanx business unit is actively working with strategic partners to bring novel, scientifically backed ingredients and products to these markets.

These product development strategies are underpinned by the company's unique ability to culture, harvest and intelligently screen its microbial collection through an integrated discovery platform that includes proprietary induction technologies such as SeaRch™.